Leukotriene Receptor Antagonists and Antiallergy Drugs (Q48939543)

17 February 2018

review article

1 reference

title

Leukotriene Receptor Antagonists and Antiallergy Drugs (English)

1 reference

17 February 2018

author name string

Tsutomu Tamada

series ordinal

1

1 reference

17 February 2018

Masakazu Ichinose

series ordinal

2

1 reference

17 February 2018

publication date

9 November 2016

1 reference

17 February 2018

Handbook of experimental pharmacology

published in

1 reference

17 February 2018

volume

237

1 reference

17 February 2018

page(s)

153-169

1 reference

17 February 2018

Cysteinyl leukotriene receptors, old and new; implications for asthma

cites work

1 reference

Cysteinyl leukotrienes and their receptors: cellular distribution and function in immune and inflammatory responses

21 January 2018

1 reference

Cysteinyl leukotrienes and their receptors; emerging concepts

21 January 2018

1 reference

Purification of a 110-kilodalton cytosolic phospholipase A2 from the human monocytic cell line U937.

21 January 2018

1 reference

Expression cloning of a cDNA for human leukotriene C4 synthase, an integral membrane protein conjugating reduced glutathione to leukotriene A4

21 January 2018

1 reference

Effect of treatment with zileuton, a 5-lipoxygenase inhibitor, in patients with asthma. A randomized controlled trial. Zileuton Clinical Trial Group

21 January 2018

1 reference

The effect of leukotriene-modifier drugs on aspirin-induced asthma and rhinitis reactions

21 January 2018

1 reference

Leukotriene E4-induced airway hyperresponsiveness of guinea pig tracheal smooth muscle to histamine and evidence for three separate sulfidopeptide leukotriene receptors

21 January 2018

1 reference

Inhaled leukotriene E(4), but not leukotriene D(4), increased airway inflammatory cells in subjects with atopic asthma

21 January 2018

1 reference

Effect of indomethacin on leukotriene4-induced histamine hyperresponsiveness in asthmatic subjects.

21 January 2018

1 reference

Identification of a murine cysteinyl leukotriene receptor by expression in Xenopus laevis oocytes

21 January 2018

1 reference

The murine cysteinyl leukotriene 2 (CysLT2) receptor. cDNA and genomic cloning, alternative splicing, and in vitro characterization

21 January 2018

1 reference

Cysteinyl leukotriene receptor 1 is also a pyrimidinergic receptor and is expressed by human mast cells

21 January 2018

1 reference

Characterization of the human cysteinyl leukotriene CysLT1 receptor

21 January 2018

1 reference

Characterization of the human cysteinyl leukotriene 2 receptor

21 January 2018

1 reference

Expression of the type 2 receptor for cysteinyl leukotrienes (CysLT2R) by human mast cells: Functional distinction from CysLT1R

21 January 2018

1 reference

CysLT2 receptors interact with CysLT1 receptors and down-modulate cysteinyl leukotriene dependent mitogenic responses of mast cells

21 January 2018

1 reference

Basic concepts in G-protein-coupled receptor homo- and heterodimerization.

21 January 2018

1 reference

Reduction of eosinophilic inflammation in the airways of patients with asthma using montelukast

21 January 2018

1 reference

Lung function improvement in asthma with a cysteinylleukotriene receptor antagonist

21 January 2018

1 reference

Leukotriene receptor antagonist, montelukast, can reduce the need for inhaled steroid while maintaining the clinical stability of asthmatic patients

21 January 2018

1 reference

Treatment of asthma with drugs modifying the leukotriene pathway.

21 January 2018

1 reference

Oral montelukast, inhaled beclomethasone, and placebo for chronic asthma. A randomized, controlled trial. Montelukast/Beclomethasone Study Group

21 January 2018

1 reference

Randomised controlled trial of montelukast plus inhaled budesonide versus double dose inhaled budesonide in adult patients with asthma

21 January 2018

1 reference

Montelukast added to inhaled beclomethasone in treatment of asthma. Montelukast/Beclomethasone Additivity Group

21 January 2018

1 reference

Leukotriene antagonists as first-line or add-on asthma-controller therapy.

21 January 2018

1 reference

Effect of oral prednisone on airway inflammatory mediators in atopic asthma

21 January 2018

1 reference

Montelukast and fluticasone compared with salmeterol and fluticasone in protecting against asthma exacerbation in adults: one year, double blind, randomised, comparative trial

21 January 2018

1 reference

Addition of montelukast or salmeterol to fluticasone for protection against asthma attacks: a randomized, double-blind, multicenter study

21 January 2018

1 reference

Comparison of the effects of intravenous and oral montelukast on airway function: a double blind, placebo controlled, three period, crossover study in asthmatic patients

21 January 2018

1 reference

A randomized placebo-controlled study of intravenous montelukast for the treatment of acute asthma

21 January 2018

1 reference

Improvement of aspirin-intolerant asthma by montelukast, a leukotriene antagonist: a randomized, double-blind, placebo-controlled trial

21 January 2018

1 reference

Churg-Strauss syndrome and leukotriene antagonist use: a respiratory perspective

21 January 2018

1 reference

CYP2C8 but not CYP3A4 is important in the pharmacokinetics of montelukast

21 January 2018

1 reference

Suicidality and montelukast

21 January 2018

1 reference

Risk of suicide attempt in asthmatic children and young adults prescribed leukotriene-modifying agents: a nested case-control study

21 January 2018

1 reference

Reports of suicidality in clinical trials of montelukast

21 January 2018

1 reference

The actual role of sodium cromoglycate in the treatment of asthma—a critical review

21 January 2018

1 reference

Effects of sodium cromoglycate and nedocromil sodium on histamine secretion from human lung mast cells.

21 January 2018

1 reference

Disodium cromoglycate inhibits activation of human inflammatory cells in vitro.

21 January 2018

1 reference

G-protein-coupled receptor 35 is a target of the asthma drugs cromolyn disodium and nedocromil sodium

21 January 2018

1 reference

Inhaled disodium cromoglycate (DSCG) as maintenance therapy in children with asthma: a systematic review

21 January 2018

1 reference

Comparison of fluticasone propionate and sodium cromoglycate for the treatment of childhood asthma (an open parallel group study).

21 January 2018

1 reference

Review of prescribed treatment for children with asthma in 1990.

21 January 2018

1 reference

Activation of pulmonary mast cells by bronchoalveolar allergen challenge. In vivo release of histamine and tryptase in atopic subjects with and without asthma

21 January 2018

1 reference

Eosinophils and mast cells in bronchoalveolar lavage in subjects with mild asthma. Relationship to bronchial hyperreactivity.

21 January 2018

1 reference

Evidence for elevated levels of histamine, prostaglandin D2, and other bronchoconstricting prostaglandins in the airways of subjects with mild asthma

21 January 2018

1 reference

Elevated bronchoalveolar lavage fluid histamine levels in allergic asthmatics are associated with methacholine bronchial hyperresponsiveness

21 January 2018

1 reference

Evidence of ongoing mast cell and eosinophil degranulation in symptomatic asthma airway

21 January 2018

1 reference

The role of histamine H1 and H4 receptors in allergic inflammation: the search for new antihistamines

21 January 2018

1 reference

Is antihistamine (H1-receptor antagonist) therapy useful in clinical asthma?

21 January 2018

1 reference

Combined antagonism of leukotrienes and histamine produces predominant inhibition of allergen-induced early and late phase airway obstruction in asthmatics

21 January 2018

1 reference

Management of allergy in the real world

21 January 2018

1 reference

Prostanoids as pharmacological targets in COPD and asthma

21 January 2018

1 reference

Prostacyclin and thromboxane synthases

21 January 2018

1 reference

Cloning and expression of cDNA for a human thromboxane A2 receptor

21 January 2018

1 reference

Cell signalling through thromboxane A2 receptors

21 January 2018

1 reference

Two thromboxane A2 receptor isoforms in human platelets. Opposite coupling to adenylyl cyclase with different sensitivity to Arg60 to Leu mutation

21 January 2018

1 reference

The source of thromboxane and prostaglandins in experimental inflammation

21 January 2018

1 reference

Thromboxanes: a new group of biologically active compounds derived from prostaglandin endoperoxides

21 January 2018

1 reference

Role of thromboxane A2 synthetase inhibitors in the treatment of patients with bronchial asthma

21 January 2018

1 reference

Thromboxane A2 and related prostaglandins in airways

21 January 2018

1 reference

Spectrum of prostanoid release after bronchoalveolar allergen challenge in atopic asthmatics and in control groups. An alteration in the ratio of bronchoconstrictive to bronchoprotective mediators

21 January 2018

1 reference

Thromboxane prostanoid receptor in human airway smooth muscle cells: a relevant role in proliferation.

21 January 2018

1 reference

Second messengers, ion channels and pharmacology of airway smooth muscle.

21 January 2018

1 reference

Provocation with adenosine 5'-monophosphate increases sputum eosinophils

21 January 2018

1 reference

Effect of a thromboxane A2 receptor antagonist (AA-2414) on bronchial hyperresponsiveness to methacholine in subjects with asthma

21 January 2018

1 reference

Effects of a thromboxane synthetase inhibitor (OKY-046) and a lipoxygenase inhibitor (AA-861) on bronchial responsiveness to acetylcholine in asthmatic subjects

21 January 2018

1 reference

7. Control of allergic airway inflammation through immunomodulation

21 January 2018

1 reference

Effects of suplatast tosilate on airway inflammation and airway hyperresponsiveness

21 January 2018

1 reference

Effect of suplatast tosilate (IPD-1151T) on cytokine production by allergen-specific human Th1 and Th2 cell lines

21 January 2018

1 reference

Effect of suplatast tosilate on airway hyperresponsiveness and inflammation in asthma patients

21 January 2018

1 reference

Effects of suplatast tosilate on allergic eosinophilic airway inflammation in patients with mild asthma

21 January 2018

1 reference

Effect of suplatast tosilate, a Th2 cytokine inhibitor, on steroid-dependent asthma: a double-blind randomised study. Tokyo Joshi-Idai Asthma Research Group

21 January 2018

1 reference

Leukotriene receptor antagonist therapy and Churg-Strauss syndrome: culprit or innocent bystander?

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1007/164_2016_72

1 reference

17 February 2018

1 reference

17 February 2018